Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 10 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.

Eligibility criteria

Qualifiers

Verbal informed consent obtained to participate in the study.

Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.

Physician, nurse practitioner, physician assistant, or nurse navigator

At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.

Disqualifiers

Non-English Speaking

Trial design

Treatments tested in this trial

  • Clinician Qualitative Interview

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators

UNC Lineberger Comprehensive Cancer Center

Lead sponsor

Conquer Cancer Foundation

Collaborator